Lifetime benefits and harms of PSA-based risk screening for prostate cancer. Heijnsdijk EAM, Gulati R, Tsodikov A, Lange JM, et al. J Natl Cancer Inst 2020 Jan 9. pii: 5698713. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Heijnsdijk EAM, Gulati R, Tsodikov A, Lange JM, et al. Lifetime benefits and harms of PSA-based risk screening for prostate cancer. J Natl Cancer Inst 2020 Jan 9. pii: 5698713. doi: 10.1093.
PMID: 32067047